Reference | Marker | Sample size | Cell type | Radiation dose | Result |
---|---|---|---|---|---|
Breast cancer | |||||
 Lou et al. 2008 [133] | Comet assay | 1. BC cases (25) | Lymphocyte | 3-Gy | Spontaneous RS |
2. Healthy controls (25) | X-rays | Healthy controls ↔ BC cases | |||
RS after radiation | |||||
BC cases > Healthy controls | |||||
 Shahidi et al. 2007 [157] | Alkaline and Neutral Comet assay | 1. BC cases (35) | Lymphocyte | Alkaline | Alkaline & Neutral Comet assay |
2. Healthy controls (29) | 1 Gy | Spontaneous RS | |||
γ-rays | BC cases > Healthy controls | ||||
Neutral | Alkaline & Neutral Comet assay | ||||
2 Gy | Initial RS | ||||
Alkaline & Neutral Comet assay | |||||
γ-rays | BC cases ↔ Healthy controls | ||||
 Djuzenova et al. 2006 [12] | Comet assay | 1. BC cases (50) | PBMC | 5 Gy | Spontaneous RS |
2. Healthy controls (16) | X-rays | BC cases ↔ Healthy controls | |||
Initial RS | |||||
BC cases ↔ Healthy controls | |||||
Residue RS | |||||
BC cases ↔ Healthy controls | |||||
 Zhang et al. 2006 [156] | Comet assay | 1. Malignant breast tumor (14) | PBMC | 0.5 Gy | Spontaneous RS |
2. Benign breast tumor (18) | γ-rays | Malignant ↔ Benign | |||
Residue RS | |||||
Malignant > Benign | |||||
BRCA1 mutation | |||||
 Kotsopoulos et al. 2007 [13] | Comet assay | 1. Healthy BRCA1 mutation carriers (25) | Lymphocyte | 2 Gy | Spontaneous RS |
2. Non-carrier control (25) | γ-rays | Healthy BRCA1 mutation carriers ↔ Non-carrier controls | |||
RS after radiation | |||||
Healthy BRCA1 mutation carriers ↔ Non-carrier controls | |||||
 Trenz et al (2002) [141] | Comet assay | 1. Healthy BRCA1 mutation carriers (5) | Lymphocyte | 2 Gy | RS after radiation |
2. Healthy BRCA2 mutation carriers (3) | γ-rays | BRCA1 mutation carriers ↔ BRCA2 | |||
3. Healthy controls W/O familial history of cancer (6) | mutation carriers | ||||
BRCA1/2 mutation carriers ↔ Healthy controls | |||||
 Rothfus et al. (2000) [142] | Comet assay | 1. Healthy BRCA1 mutation carriers (12) | Lymphocyte | 2 Gy | RS after radiation |
2. Non-carrier subjects from BRCA1 families (10) | γ-rays | No difference across all groups | |||
3. Healthy controls W/O history of cancer (17) | |||||
Radiotherapy complications | |||||
 Djuzenova et al. 2006 [12] | Comet assay | 1. BC cases with ASR (9) | PBMC | 5 Gy | Spontaneous RS |
2. BC cases (50) | X-rays | BC with ASR ↔ Healthy controls | |||
3. Healthy controls (16) | BC with ASR ↔ BC cases | ||||
RS after radiation | |||||
BC with ASR ↔ Healthy controls | |||||
BC with ASR ↔ BC cases | |||||
 Oppitz et al. 2002 [158] | Comet assay | 1. BC cases (32) | Lymphocyte & Fibroblast | Lymphocyte | Lymphocyte |
A. Lymphocyte (30) | 3Gy | RS after radiation | |||
B. Fibroblast (26) | Fibroblast | Elevated acute reactions > Average acute reactions | |||
5Gy | Fibroblast | ||||
Radiosensitivity after radiation | |||||
Elevated acute reactions ↔ Average acute reactions |